首页> 外国专利> Procedure for the determination of an in vitro dose of antibiotic by genetic regulatory mechanisms and corresponding diagnostic kit

Procedure for the determination of an in vitro dose of antibiotic by genetic regulatory mechanisms and corresponding diagnostic kit

机译:通过遗传调控机制和相应的诊断试剂盒确定抗生素体外剂量的程序

摘要

said kit intended auna implementation kit for detecting and / or quantifying an antibiotic (C), belonging to the family of tetracyclines or lasvirginiamicinas present in a test sample, by a receiver (A), wherein in vitro, ie unexpressed in any biological or cellular system, characterized porqueconsiste the following reagents: - a receiver mode (a), a genetic repressor respectively tetracycline or virginiamycin, which present it property exhibiting at least a first site specific recognition for antibiotic (C) and unsegundo recognition site specific for a nucleotide sequence operator (B) corresponding alrepresor, the second site separate from the first site, and has the property that fixing nucleotide dichasecuencia (B) in the receiver (a) in said second specific recognition site is modulanegativamente by fixing aNTIBIOTIC or (C) in the receiver (A) in said first site reconocimientoespecífico, ie fixing said nucleotide sequence (B) occurs only in defijación absence of the antibiotic (C) in the receiver (A), - said sequence nucleotide (B), single or double stranded.
机译:所述试剂盒旨在用于通过接收器(A)检测和/或定量存在于测试样品中的四环素或lasvirginiamicinas家族的抗生素(C)的动物实施试剂盒,其中在体外,即在任何生物或细胞中未表达系统,其特征在于由以下试剂组成:-受体模式(a),分别是四环素或维吉尼亚霉素的遗传阻抑物,其表现出至少对抗生素(C)的第一位点特异性识别和对核苷酸序列具有特异性的unsegundo识别位点的特性(B)对应的操纵基因,第二位点与第一位点分开,并具有以下特性:通过在第二特异性识别位点中将受体(a)中的核苷酸双歧化酶(B)固定在所述第二特异性识别位点中,可以通过调节氨基丁酸或(C)将其固定。所述第一位点reconocimientoespecífico中的受体(A),即固定所述核苷酸序列(B)仅在缺乏抗生素(C)的情况下发生在受体(A)中,-所述序列核苷酸(B),单链或双链。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号